POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New osteoporosis drug put to safety test in indian women
Disease control CompletedThis study tested the safety and side effects of a bone-building medication called romosozumab (EVENITY®) in 100 postmenopausal women in India who have osteoporosis and a high risk of breaking a bone. The main goal was to see how well the women tolerated the drug and to monitor f…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New bone drug aims to match leading treatment for postmenopausal women
Disease control CompletedThis study tested whether a new drug called ENZ215 works as well as the approved drug Prolia for treating osteoporosis in postmenopausal women. It involved 504 women who received injections of either drug and were monitored for 12 months. The main goal was to see if the new drug …
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC